This site is for informational purposes only. We are not medical professionals. Adults only (18+).

Nootropic / Anxiolytic

Selank

Selank is a synthetic heptapeptide derived from the endogenous neuropeptide tuftsin. Originally developed in Russia, it has been studied primarily for anxiolytic and nootropic effects, and holds approved status in Russia for anxiety and immunomodulation.

What is Selank?

Selank (Thr-Lys-Pro-Arg-Pro-Gly-Pro) was developed at the Institute of Molecular Genetics of the Russian Academy of Sciences as a stable analogue of tuftsin, a tetrapeptide that plays a role in immune regulation. By adding three additional amino acids (Pro-Gly-Pro), researchers created a compound with enhanced metabolic stability and CNS activity.

Selank is approved in Russia as a pharmaceutical drug (under the brand name Selank) for generalized anxiety disorder and as a nootropic. Outside Russia, it remains a research compound with no regulatory approval.

Mechanism of Action

Selank's precise mechanism of action is not fully characterized, but several pathways have been identified in preclinical research:

GABAergic Modulation

Selank appears to enhance the function of the GABAergic system — the primary inhibitory neurotransmitter system in the brain — which may underlie its anxiolytic effects. Unlike benzodiazepines, it does not directly bind to GABA-A receptors, suggesting a modulatory rather than direct agonist mechanism.

Enkephalin Stabilization

Research suggests Selank inhibits enkephalin-degrading enzymes, increasing levels of endogenous enkephalins (endogenous opioid peptides involved in mood and stress regulation).

BDNF & Serotonin Interaction

Some studies indicate Selank influences brain-derived neurotrophic factor (BDNF) expression and interacts with serotonergic pathways, which may contribute to its reported cognitive and mood effects.

Immunomodulation

As a tuftsin analogue, Selank retains some of tuftsin's immunomodulatory properties, with animal research suggesting effects on cytokine expression (notably IL-6) and natural killer cell activity.

Research Overview

The majority of Selank research originates from Russian institutions and has been published predominantly in Russian-language journals, limiting independent replication in Western research settings. The quality and design of available studies varies considerably.

  • Anxiety: Russian clinical trials with generalized anxiety disorder patients report significant reductions in anxiety scores with intranasal Selank, with effects described as comparable to benzodiazepines but without sedation or dependence.
  • Cognition: Preclinical data shows improvements in memory consolidation and learning in rodent models. Human data on cognitive enhancement is limited and primarily observational.
  • Immune function: Animal and in vitro studies suggest Selank modulates cytokine expression, though the clinical significance of this in healthy humans is unclear.
  • PTSD & stress: Some Russian research examined Selank in stress-related conditions with promising preliminary results, but robust RCT data is lacking.

Potential Benefits

Based on available research. Not medical claims.

  • Anxiolytic effects without reported sedation or dependence
  • May support working memory and learning
  • Potential immunomodulatory activity
  • Reported mood stabilization
  • May reduce stress-related cognitive impairment
  • Well-tolerated in available clinical data with low reported side effects

Safety Profile

Selank has a notably favorable safety profile in available clinical data compared to traditional anxiolytics. Key considerations:

  • No physical dependence or withdrawal has been reported in clinical trials, in contrast to benzodiazepines.
  • Sedation is not a commonly reported side effect at therapeutic doses.
  • Long-term safety data beyond the Russian clinical trials is not available.
  • The research literature is largely from a single research tradition — independent replication is limited.
  • Route of administration (intranasal) may affect outcomes compared to injectable forms available on the gray market.
  • Drug interaction profile with modern pharmaceuticals is not well characterized.

Related Reading

Disclaimer

The information on this page is for educational and informational purposes only. It is not intended as medical advice. We are not medical professionals. All compounds discussed are intended for research purposes only. Always consult with a qualified healthcare professional before making any decisions about peptides or supplements. Individual results may vary. See our full disclaimer.

Affiliate Disclosure: This page contains affiliate links. We only recommend vendors we have personally vetted for COA compliance. We may earn a commission at no extra cost to you.